3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization

Introduction Volume changes induced by selective internal radiation therapy (SIRT) may increase the possibility of tumor resection in patients with insufficient future liver remnant (FLR). The aim was to identify dosimetric and clinical parameters associated with contralateral hepatic hypertrophy after lobar/extended lobar SIRT with Y-90-resin microspheres. Materials and methods Patients underwent Y-90 PET/CT after lobar or extended lobar (right + segment IV) SIRT. Y-90 voxel dosimetry was retrospectively performed (PLANET Dose; DOSIsoft SA). Mean absorbed doses to tumoral/non-tumoral-treated volumes (NTL) and dose-volume histograms were extracted. Clinical variables were collected. Patients were stratified by FLR at baseline (T0-FLR): < 30% (would require hypertrophy) and >= 30%. Changes in volume of the treated, non-treated liver, and FLR were calculated at < 2 (T1), 2-5 (T2), and 6-12 months (T3) post-SIRT. Univariable and multivariable regression analyses were performed to identify predictors of atrophy, hypertrophy, and increase in FLR. The best cut-off value to predict an increase of FLR to >= 40% was defined using ROC analysis. Results Fifty-six patients were studied; most had primary liver tumors (71.4%), 40.4% had cirrhosis, and 39.3% had been previously treated with chemotherapy. FLR in patients with T0-FLR < 30% increased progressively (T0: 25.2%; T1: 32.7%; T2: 38.1%; T3: 44.7%). No dosimetric parameter predicted atrophy. Both NTL-Dmean and NTL-V30 (fraction of NTL exposed to >= 30 Gy) were predictive of increase in FLR in patients with T0 FLR < 30%, the latter also in the total cohort of patients. Hypertrophy was not significantly associated with tumor dose or tumor size. When >= 49% of NTL received >= 30 Gy, FLR increased to >= 40% (accuracy: 76.4% in all patients and 80.95% in T0-FLR < 30% patients). Conclusion NTL-Dmean and NTL exposed to >= 30 Gy (NTL-V30) were most significantly associated with increase in FLR (particularly among patients with T0-FLR < 30%). When half of NTL received >= 30 Gy, FLR increased to >= 40%, with higher accuracy among patients with T0-FLR < 30%.

Automated summary

This study identified that the mean absorbed dose in non-tumoral treated volumes (NTL-Dmean) and the fraction of NTL exposed to >= 30 Gy (NTL-V30) were significantly associated with an increase in future liver remnant (FLR) after lobar/extended lobar SIRT with Y-90-resin microspheres, particularly among patients with T0-FLR < 30%. When >= 49% of NTL received >= 30 Gy, FLR increased to >= 40% with higher accuracy among patients with T0-FLR < 30%.